Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production

Current Drug Delivery

Volumn 9, Issue 3, 2012, Pages 269-284

  Sheth, Pratik ^a,b   Sandhu, Harpreet ^a   Singhal, Dharmendra ^a   Malick, Waseem ^a   Shah, Navnit ^a   Kislalioglu, M Serpil ^b  

^a HOFFMANN LA ROCHE INC   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Nanoparticles; Nanoparticulated drugs; PGSS; RESS; SAS; SEDS; Supercritical fluids

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; APREPITANT; ASPARAGINASE MACROGOL; CARBON DIOXIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ESTRADIOL; FENOFIBRATE; GLATIRAMER; HEPATITIS A VACCINE; INFLUENZA VACCINE; MAGNAGEL; MEGESTROL ACETATE; NANOPARTICLE; NANOXOSAN 30; ORGANIC SOLVENT; PACLITAXEL; PACLITAXEL POLIGLUMEX; PEGADEMASE; PEGAPTANIB; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PEGVISOMANT; PHOTOSENSITIZING AGENT; POLYMER; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEVELAMER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERTEPORFIN;

AERODYNAMICS; CRYSTALLIZATION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG SYNTHESIS; DYNAMICS; EVAPORATION; MATERIAL STATE; NANOTECHNOLOGY; PARTICLE SIZE; PARTICLES FROM GAS SATURATED SOLUTION; PRIORITY JOURNAL; RAPID EXPANSION OF SUPERCRITICAL SOLUTION; REVIEW; SOLUBILIZATION; SUPERCRITICAL ANTI SOLVENT; SUPERCRITICAL STATE; SURFACE PROPERTY; TEMPERATURE MEASUREMENT; THERMODYNAMICS; VACUUM;

EID: 84860523346     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112800389052     Document Type: Review

References (104)

1. Hecq, J. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm., 2005, 299, 167-177.
2. Keck, C.M.; Muller, R.H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm., 2006, 62(1), 3-16.
3. Merisko-Liversidge, E.; Liversidge, G.G.; Cooper, E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci., 2003, 18(2), 113-120.
4. Muller, R.H.; B hm, B.H.L.; Grau, M.J.; Wise, D.L. Nanosuspensions a formulation approach for poorly soluble and poorly bioavailable drugs. Handbook of Pharmaceutical Controlled Release Marcel Dekker, New York, 2000, pp. 345-357.
5. Noyes, A.A.; Whitney, W. Auflösungsgeschwindigkeit von festen Stoffen in ihren eigenen Lösungen. Z. Physik. Chemie., 1897, 23, 689-692.
6. Junghanns, J.U.; Müller, R.H. Nanocrystal technology, drug delivery and clinical applications. Int. J. Nanomed., 2008, 3(3), 295-310.
7. Nelson, K.G. The Kelvin equation and solubility of small particles. J. Pharm. Sci., 1972, 61, 479-480.
8. Wagner, V.; Dullaart, A.; Bock, A. K.; Zweck, A. The emerging nanomedicine landscape. Nat. Biotechnol., 2006, 24(10), 1211-1217.
9. Wagner, V.; Husing, B.; Gaisser, S. Nanomedicine: Drivers for development and possible impacts, European Commission joint research center report. October, 2006.
10. Liedtke, S.; Wissing, S.; Müller, R.H.; Mäder, K. Influence of high pressure homogenization equipment on nanodispersions characteristics. Int. J. Pharm., 2000, 196(2), 183-185.
11. Cho, J.S.; Ko, Y.N.; Koo, H.Y.; Kang, Y.C. Synthesis of nano-sized biphasic calcium phosphate ceramics with spherical shape by flame spray pyrolysis. J. Mater. Sci. Mater. Med., 2010, 4, 1143-1149.
12. Patey, T.J.; Büchel, R.; Nakayama, M.; Novák, P. Electrochemistry of LiMn2O4 nanoparticles made by flame spray pyrolysis. Phys. Chem. Chem. Phys, 2009, 11(19), 3756-3761.
13. Beliatis, M.J.; Martin, N.A.; Leming, E.J.; Silva, S.R.; Henley, S.J. Laser ablation direct writing of metal nanoparticles for hydrogen and humidity sensors. Langmuir, 2011, 27(3), 1241-1244.
14. Hulteen, J.C.; Treichel, D.A.; Smith, M.T.; Duval, M.L.; Jensen, T.R.; Van Duyne, R.P. Nanosphere Lithography: Size-Tunable Silver Nanoparticle and Surface Cluster Arrays. J. Phys. Chem. B, 1999, 103, 3854-3863.
15. Yasuji, T.; Takeuchi, H.; Kawashima, Y. Particle design of poorly water-soluble drug substances using supercritical fluid technologies. Adv. Drug Deliv. Rev., 2008, 60(3), 388-398.
16. Mishima, K. Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas. Adv. Drug Deliv. Rev., 2008, 60(3), 411-432.
17. Youn, Y.S.; Oh, J.H.; Ahn, K.H.; Kim, M.; Kim, J.; Lee, Y.W. Dissolution rate improvement of valsartan by low temperature recrystallization in compressed CO2: Prevention of excessive agglomeration. J. Supercrit. Fluids, 2011, 59, 117-123.
18. Donsi, G.; Reverchon, E. Micronization by means of supercritical fluids: possibility of application to pharmaceutical field. Pharm. Acta Helv., 1991, 66(5-6), 170-173.
19. Kerc, J.; Srcic, S.; Knez, Z.; Sencar-Bozic, P. Micronization of drugs using supercritical carbon dioxide. Int. J. Pharm., 1999, 182(1), 33-39.
20. Snavely, W.K.; Subramaniam, B.; Rajewski, R.A.; Defelippis, M.R. Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent. J. Pharm. Sci., 2002, 91, 2026-2039.
21. Mohamed, R.S.; Halverson, D.S.; Debendetti, P.G.; Prud'homme, R.K. Solid formation after the expansion of supercritical mixtures, Supercritical fluid science and technology. In: Johnston K.P., Penninger, JML (eds), ACS Symposium series-406, American Chemical Society, Washington DC, 1989, 355-378.
22. Pathak, P.; Meziani, M.J.; Desai, T.; Sun, Y.P. Nanosizing drug particles in supercritical fluid processing. J. Am. Chem. Soc., 2004, 126(35), 10842-10843.
23. Pasquali, I.; Bettini, R.; Giordano, F. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur. J. Pharm. Sci., 2006, 27(4), 299-310.
24. Herberger, J.; Murphy, K.; Munyakazi, L.; Cordia, J.; Westhaus, E. Carbon dioxide extraction of residual solvents in poly(lactide-coglycolide) microparticles. J. Control. Release, 2003, 90(2), 181-195.
25. Ruchatz, F.; Kleinebudde, P.; Muller, B.W. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process. J. Pharm. Sci., 1997, 86, 101-105.
26. Falk, R.F.; Randolph, T.W. Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles. Pharm. Res., 1998, 15(8), 1233-1237.
27. Kamihira, M.; Taniguchi, M.; Kobayashi, T. Removal of organic solvent from antibiotics with supercritical carbon dioxide. J. Ferment. Technol., 1987, 65(1), 71-75.
28. Kazarian, S.G.; Martirosyan, G.G. Spectroscopy of polymer/drug formulations processed with supercritical fluids: in situ ATR-IR and Raman study of impregnation of ibuprofen into PVP. Int. J. Pharm., 2002, 232(1-2), 81-90.
29. Lee, S.; Nam, K.; Kim, M.S.; Jun, S.W.; Park, J.S.; Woo, J.S. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability. Arch. Pharm. Res., 2005, 28, 866-874.
30. Berens, A.R.; Huvard, G.S.; Korsmeyer, R.W. Process for incorporating an additive into a polymer and product produced thereby. US Patent 4820752, April 11, 1989
31. Wang, Y.; Dave, R.N.; Pfeffer, R. Polymer coating/encapsulation of nanoparticles using a supercritical anti-solvent process. J. Supercrit. Fluids., 2004, 28, 85-99.
32. Subramaniam, B.; Saim, S.; Rajewski, R.; Stella, V.J. Methods and Apparatus for Particle Precipitation and Coating Using Near-Critical and Supercritical Antisolvents. US Patent 5,833,891, Nov 10, 1998.
33. Chattopadhyay, P.; Huff, R.; Shekunov, B.Y. Drug encapsulation using supercritical fluid extraction of emulsions. J. Pharm. Sci., 2006, 95, 667-679.
34. Cooper, A.I. Polymer synthesis and processing using supercritical carbon dioxide. J. Mater. Chem., 2000, 10, 207-234.
35. Kendall, J.L.; Canelas, D.A.; Young, J.L.; DeSimone, J.M. Polymerization in supercritical carbon dioxide. Chem. Rev., 1999, 99, 543-563.
36. Tomasko, D.L.; Li, H.; Liu, D.; Han, X.; Wingert, M.J.; Lee, L.J.; Koelling, K.W. A review of CO2 applications in the processing of polymers. Ind. Eng. Chem. Res, 2003, 42, 6431-6456.
37. Woods, H.M.; Silva, M.M.C.G.; Nouvel, C.; Shakesheff, K.M.; Howdle, S.M. Materials processing in supercritical carbon dioxide: surfactants, polymers and biomaterials. J. Mater. Chem., 2004, 14(11), 1663-1678.
38. Yeo, S.; Kiran, E. Formation of polymer particles with supercritical fluids: A review. J. Supercrit. Fluids, 2005, 34(3), 287-308.
39. Kiran, E. Polymer miscibility, phase separation, morphological modifications and polymorphic transformations in dense fluids. J. Supercrit. Fluids, 2009, 47, 466-483.
40. Lee, M.; Tzoganakis, C.; Park, C.B. Extrusion of PE/PS blends with supercritical carbon dioxide. Polym. Eng. Sci. 1998, 38(7), 1112-1120.
41. Lyons, J.G.; Hallinan, M.; Kennedy, J.E.; Devine, D.M.; Geever, L.M.; Blackie, P. Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process. Int. J. Pharm., 2007, 329(1-2), 62-71.
42. Andrews, G.P.; Abu-Diak, O.; Kusmanto, F.; Hornsby, P.; Hui, Z.; Jones, D.S. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J. Pharm. Pharmacol., 2010, 62(11), 1580-1590.
43. Frederiksen, L.; Anton, K.; van Hoogevest, P.; Keller, H.R.; Leuenberger, H. Preparation of liposomes encapsulating water-soluble compounds using supercritical carbon dioxide. J. Pharm. Sci., 1997, 86(8), 921-928.
44. Hassan, H.A.; Al-Marzouqi, A.H.; Jobe, B.; Hamza, A.A.; Ramadan, G.A. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide. J. Pharm. Biomed. Anal., 2007, 45, 243-250.
45. Kamihira, M.; Taniguchi, M.; Kobayashi, T. Sterilization of microorganisms with supercritical carbon dioxide. Agric. Biol. Chem., 1987, 51, 407-412.
46. Hong, S.; Pyun, Y. Inactivation Kinetics of Lactobacillus plantarum by High Pressure Carbon Dioxide. J. Food Sci., 1999, 64(4), 728-733.
47. Isenschmid, A.; Marison, I.W.; von Stockar, U. The influence of pressure and temperature of compressed CO2 on the survival of yeast cells. J. Biotechnol., 1995, 39(3), 229-237
48. Andersson, M.B.O.; Demirbüker, M.; Blomberg, L.G. Semicontinuous extraction/purification of lipids by means of supercritical fluids. J. Chromatogr. A, 1997, 785(1-2), 337-343.
49. Kallio, M.H. Supercritical fluid chromatography-gas chromatography of volatiles in cloudberry (Rubus chamaemorus) oil extracted with supercritical carbon dioxide. J. Chromatogr. A, 1997, 787, 276-282.
50. Dabbousi, B.O.; Rodriguez-Viejo, J.; Mikulec, F.V.; Heine, J.R.; Mattoussi, H.; Ober, R. (CdSe)ZnS Core Shell Quantum Dots: Synthesis and Characterization of a Size Series of Highly Luminescent Nanocrystallites. J. Phys. Chem. B, 1997, 101(46), 9463-9475.
51. Medintz, I.L.; Uyeda, H.T.; Goldman, E.R.; Mattoussi, H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater., 2005, 4(6), 435-446.
52. Reverchon, E.; Cardea, S.; Production of controlled polymeric foams by supercritical CO2. J. Supercrit. Fluids. 2007, 40, 144-152.
53. Arora, K.A.; Lesser, A.J.; McCarthy, T.J. Preparation and Characterization of Microcellular Polystyrene Foams Processed in Supercritical Carbon Dioxide. Macromolecules, 1998, 31(14), 4614-4620.
54. Marr, R.; Gamse, T.; Use of supercritical fluids for different processes including new developments-a review. Chem. Eng. Process., 2000, 39, 19-28.
55. Pathak, P.; Meziani, M.J.; Sun, Y.P. Supercritical fluid technology for enhanced drug delivery. Expert Opin. Drug. Deliv., 2005, 2(4) 747-761.
56. Jung, J.; Perrut, M. Particle design using supercritical fluids: literature and patent survey. J. Supercrit. Fluids, 2001, 20, 179-219.
57. Kompella, U.B.; Koushik, K.; Preparation of drug delivery systems using supercritical fluid technology. Crit. Rev. Ther. Drug Carr. Syst., 2001, 18(2), 173-199.
58. Castor, T.P. Phospholipid nanosomes. Curr. Drug. Deliv., 2004, 2(4), 329-340.
59. Tan, H.S.; Borsadia, S.; Particle formation using supercritical fluids: pharmaceutical applications. Expert Opin. Ther. Pat., 2001, 11(5), 861-872.
60. Stanton, L.A.; Dehghani, F.; Foster, N.R. Improving drug delivery using polymers and supercritical fluid technology. Aust. J. Chem., 2002, 55(6-7), 443-447.
61. Ye, X.; Wai, C.M.; Making nanomaterials in supercritical fluids: a review. J. Chem. Educ., 2003, 80(2), 198-204.
62. Vemavarapu, C.; Mollan, M.J.; Lodaya, M.; Needham, T.E. Design and process aspects of laboratory scale SCF particle formation systems. Int. J. Pharm., 2005, 292(1-2), 1-16.
63. Byrappa, K.; Ohara, S.; Adschiri, T. Nanoparticles synthesis using supercritical fluid technology towards biomedical applications. Adv. Drug Deliv. Rev., 2008, 60(3), 299-327.
64. Pasquali, I.; Bettini, R.; Giordano, F.; Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals. Adv. Drug Deliv. Rev. 2008, 60(3), 399-410.
65. Pasquali, I.; Bettini, R.; Are pharmaceutics really going supercritical?. Int. J. Pharm., 2008, 364(2), 176-187.
66. Maulvi, F.; Thakkar, V.T.; Soni, T.G.; Gohel, M.C.; Gandhi, T.R.; Supercritical fluid technology: A promising approach to enhance the drug solubility. J. Pharm. Sci. Res., 2009, 1, 1-14.
67. Palakodaty, S.; York, P.; Phase behavioral effects on the particle formation processes using supercritical fluid. Pharm. Res., 1999, 16, 976-985.
68. Reverchon, E.; Caputo, G.; Marco, I.D. Role of Phase Behavior and Atomization in the Supercritical Antisolvent Precipitation. Ind. Eng. Chem. Res., 2003, 42, 6406-6414.
69. Perrut, M.; Clavier, J.Y.; Supercritical Fluid Formulation: Process Choice and Scale-up. Ind. Eng. Chem. Res. 2003, 42(25), 6375-6383.
70. Kwauk, X.; Debenedetti, P.G. Mathematical modeling of aerosol formation by rapid expansion of supercritical solutions in a converging nozzle. J. Aerosol Sci., 1993, 24(4), 445-469.
71. Reverchon, E.; Pallado, P. Hydrodynamic modeling of the RESS process. J. Supercrit. Fluids, 1996, 9, 216-221.
72. Hirunsit, P.; Huang, Z.; Srinophakun, T.; Charoenchaitrakool, M.; Kawi, S. Particle formation of ibuprofen-supercritical CO2 system from rapid expansion of supercritical solutions (RESS): A mathematical model. Powder Technol., 2005, 154, 83-94.
73. Türk, M. Influence of thermodynamic behavior and solute properties on homogeneous nucleation in supercritical solutions. J. Supercrit. Fluids., 2000, 18, 169-184
74. Helfgen, B.; Hils, P.; Holzknecht, Ch.; Türk, M.; Schaber, K. Simulation of particle formation during the rapid expansion of supercritical solutions. J. Aerosol Sci., 2001, 32(3), 295-319.
75. Weber, M.; Russell, L.M.; Debenedetti, P.G. Mathematical modeling of nucleation and growth of particles formed by the rapid expansion of a supercritical solution under subsonic conditions. J. Supercrit. Fluids, 2002, 23, 65-80.
76. Lengsfeld, C.S.; Delplanque, J.P.; Barocas, V.H.; Randolph, T.W. Mechanism governing microparticle morphology during precipitation by a compressed antisolvent: Atomization vs nucleation and growth. J. Phys. Chem. B, 2000, 104(12), 2725-2735.
77. Werling, J.O.; Debenedetti, P.G. Numerical modeling of mass transfer in the supercritical antisolvent process: miscible conditions. J. Supercrit. Fluids, 2000, 18, 11-24.
78. Reverchon, E.; Adami, R.; Caputo, G.; De Marco I. Spherical microparticles production by supercritical antisolvent precipitation: Interpretation of results. J. Supercrit. Fluids, 2008, 47, 70-84.
79. Braeuer, A.; Dowy, S.; Torino, E.; Rossmann, M.; Luther, S. K.; Schluecker, E.; Leipertz, A; Reverchon, E. Analysis of the supercritical antisolvent mechanisms governing particles precipitation and morphology by in situ laser scattering techniques. Chem. Engg. J., 2011, 173, 258-266.
80. Mishima, K.; Matsuyama, K. Method for preparing composite fine particles, Japan Patent, WO 057374, 2006.
81. Gadermann, M.; Kular, S.; Al-Marzouqi, A.; Signorell, R. Formation of naproxen/polylactic acid nanoparticles by pulsed rapid expansion of supercritical solutions. Phys. Chem. Chem. Phys., 2009, 11, 7861-7868.
82. Varshosaz, J.; Hassanzadeh, F.; Mahmoudzadeh, M.; Sadeghi, A.; Preparation of cefuroxime axetil nanoparticles by rapid expansion of supercritical fluid technology. Powder Technol., 2009, 189(1), 97-102.
83. Reverchon, E.; Donsi, G.; Gorgoglione, D. Salicylic acid solubilization in supercritical CO2 and its micronization by RESS. J. Supercrit. Fluids, 1993, 6(4), 241-248.
84. Young, T.; Pace, G.; Johnston, K.P.; Mishra, A. Phospholipidstabilized nanoparticles of cyclosporine-A by rapid expansion from supercritical to aqueous solution. AAPS Pharm. Sci. Tech. 2004, 5(1), 70-85.
85. Tozuka, Y.; Miyazaki, Y.; Takeuchi, H. A combinational supercritical CO2 system for nanoparticle preparation of Indomethacin. Int. J. Pharm., 2010, 386(1-2), 243-248.
86. Thakur R., Gupta, R.B. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process, Int. J. Pharm., 2006, 308(1-2), 190-199.
87. Jung, J.; Clavier, J.Y.; Perrut, M. Gram to kilogram scale up of supercritical anti-solvent process. Proceedings of the 6th International Symposium on Supercritical Fluids. Versailles (France), 1683-1688, 2003.
88. Kalogiannis, C.G.; Pavlidou, E.; Panayiotou, C.G. Production of Amoxicillin Microparticles by Supercritical Antisolvent Precipitation. Ind. Eng. Chem. Res., 2005, 44(24), 9339-9346.
89. Reverchon, E.; De Marco, I.; Della Porta, G. Rifampicin microparticles production by supercritical antisolvent precipitation. Int. J. Pharm., 2002, 243(1-2), 83-91.
90. Park, J.; Park, H.J.; Cho, W.; Cha, K.; Kang, Y.; Hwang, S. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process. Int. J. Pharm., 2010, 396(1-2), 239-245.
91. Sanganwar, G.P.; Sathigari, S.; Babu, R.J.; Gupta, R.B. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement. Eur. J. Pharm. Sci., 2010, 39(1-3), 164-174.
92. Chattopadhyay P., Gupta, R. Production of griseofulvin nanoparticles using supercritical CO2 antisolvent with enhanced mass transfer. Int. J. Pharm. 2001, 228(1-2), 19-31.
93. Reverchon, E. Supercritical-Assisted Atomization to Produce Microand/or Nanoparticles of Controlled Size and Distribution. Ind. Eng. Chem. Res., 2002, 41 (10), 2405-2411.
94. Rodrigues, M. A.; Padrela, L.; Geraldes, V.; Santos, J.; Matos, H. A.; Azevedo, E. G. Theophylline Polymorphs by Atomization of Supercritical Antisolvent Induced Suspensions. J. Supercrit Fluids, 2011, 58 (2), 303-312.
95. Hanna, M.; York, P. World Patent WO 95/01221, 1994.
96. Ghaderi, R.; Artursson, P.; Carlfors, J. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in dl-PLG microparticles using supercritical fluids. Eur. J. Pharm. Sci., 2000, 10(1), 1-9.
97. Chen, A.; Li, Y.; Chau, F.; Lau, T.; Hu, J.; Zhao, Z. Microencapsulation of puerarin nanoparticles by poly(l-lactide) in a supercritical CO2 process, Acta Biomaterialia, 2009, 5(8), 2913-2919.
98. Sencar-Bozic, P.; Srcic, S.; Knez, Z.; Kerc, J. Improvement of nifedipine dissolution characteristics using supercritical CO2. Int. J. Pharm., 1997, 148, 123-130.
99. Rodrigues, M.; Peiriço, N.; Matos, H.A.; Gomes de Azevedo, E.; Lobato, M.R.; Almeida, A.J. Microcomposites theophyl-line/hydrogenated palm oil from a PGSS process for controlled drug delivery systems. J. Supercrit. Fluids, 2004, 29(1-2), 175-184.
100. Weidner, E. High pressure micronization for food applications. J. Supercrit. Fluids, 2009, 47(3), 556-565.
101. Shekunov, B.Y.; Chattopadhyay, P.; Seitzinger, J.S. Method and apparatus for enhanced size reduction of particles using liquefaction of materials, US Patent 6,986,846, January 17, 2006.
102. Hu, X.; Guo, Y.; Wang, L.; Hua, D.; Hong, Y.; Li, J. Coenzyme Q10 nanoparticles prepared by a supercritical fluid-based method. J. Supercrit Fluids, 2011, 57, 66-72.
103. Martin, A.; Weidner, E. PGSS-drying, mechanisms and modeling. J. Supercrit Fluids, 2010, 55(1), 271-281.
104. ®. J. Supercrit Fluids, 2003, 26(1), 9-16.